All News

Pharmacy directors see pipeline chock full of specialty drugs and compounds.

A trio of late-breaking clinical trials could change standard drug treatment for patients undergoing percutaneous coronary intervention, or PCI.

Company develops software to place barcodes on hospital's IV smart pumps, allowing it to track the pumps throughout the facility.

The FDA has approved Ixabepilone (Ixempra) as a monotherapy and in combination with capecitabine (Xeloda) for patients with metastic or locally advanced breast cancer.

While there still is a great deal of variation in the MTM programs for 2007, pharmacist involvement has increased relative to the degree of pharmacist involvement in 2006.

Pharmacies that sell DMEPOS supplies to Medicare patients face a variety of options for accreditation.

Arxcel's prescription benefits survey for 2007 reveals the impact of and perceptions toward prescription benefits provided as a part of employee health benefits in corporate America.

New Medicare rule cuts reimbursement for class of non-Hodgkins lymphoma treatments

More than three million seniors will benefit from networked medical sensors at home in 2012.

White paper focuses on managing hazardous pharmaceutical waste in hospitals

New guides outline latest evidence on Type 2 diabetes medications

A new report funded by AHRQ offers findings on which medications work better to treat rheumatoid arthritis

FDA approves allergy treatment Zyrtec (cetirizine HCl) for over-the-counter use

The Centers for Medicare and Medicaid Services has proposed a rule that would create a new standard for electronic prescriptions for the Medicare Part D program.

GSK gets OTC marketing rights from Merck for Mevacor

Changes in compounding standards take effect on June 1, 2008

A final rule from the DEA allows doctors to give patients multiple prescriptions for up to a 90-day supply of Schedule II controlled substances.

The new products include branded drugs, new formulations, new indications, and new dosing, along with OTCs and home health and beauty items.

New drugs in development for age-related macular degeneration (AMD).

Patience and cooperation have been the hallmarks of an award-winning career in Alzheimer's care for pharmacist Robert Cluxton.

Pharmacists' organizations were out in force at a recent FDA hearing on the possibility of creating a third category of drugs that would be placed "behind-the-counter" and pharmacist-assisted.

This stockchecker from Hamacher discusses family planning products.

Indepedent pharmacies expect holiday 2007 to be an excellent sales year. This article describes some of the gifts and decorations they will be selling.

GPhA urges state governments to increase access to generics

ASHP will hold a meeting with several other organizations to study how infusion-related errors can be eliminated.

DEA issues rule on Schedule I positional isomers

Three Take Care Health Clinics open at Walgreens in Nashville

GPhA urges state governments to increase access to generics